Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study.

@article{Meyer2008CombinedTO,
  title={Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study.},
  author={Carsten H. Meyer and Hendrik P. N. Scholl and Nicole Eter and Hans-Martin Helb and Frank G. Holz},
  journal={Acta ophthalmologica},
  year={2008},
  volume={86 5},
  pages={490-4}
}
PURPOSE To assess the effectiveness of consecutive intravitreal injections of recombined tissue plasminogen activator (rtPA), expansile gas and bevacizumab in eyes with acute subretinal haemorrhage (SRH). METHODS A retrospective, non-randomized consecutive case series included 19 eyes in 19 patients with SRH related to exudative age-related macular degeneration (AMD). The initial size of the subfoveal SRH was 1-3 disc diameters. Each patient received a triple procedure using 0.05 ml rtPA (50… CONTINUE READING